Inge De Wandele1, Lies Rombaut2, Luc Leybaert3, Philippe Van de Borne4, Tine De Backer5, Fransiska Malfait6, Anne De Paepe6, Patrick Calders2. 1. Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Artevelde University College, De Pintelaan 185, 1B3, 9000 Ghent, Belgium. Electronic address: inge.dewandele@ugent.be. 2. Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Artevelde University College, De Pintelaan 185, 1B3, 9000 Ghent, Belgium. 3. Department of Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium. 4. Hypertension Clinic, Erasme Hospital, Brussels, Belgium. 5. Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium. 6. Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Abstract
OBJECTIVES: Many non-musculoskeletal complaints in EDS-HT may be related to dysautonomia. This study therefore aims to investigate whether dysautonomia is present and to explore the underlying mechanisms. METHODS: A total of 39 females with EDS-HT and 35 age-matched controls underwent autonomic function testing. Resting autonomic tone was assessed using heart rate variability (frequency domain) and baroreflex sensitivity analysis (cross correlation). Autonomic reactivity was assessed using the Autonomic Reflex Screen test battery. Factors suspected to contribute to dysautonomia, e.g., neuropathy, medication use, decreased physical activity, depression, pain-induced sympathetic arousal, and connective tissue laxity, were quantified using validated questionnaires, the Beighton score, and measurement of skin extensibility. RESULTS: The EDS-HT group showed autonomic deregulation with increased sympathetic activity at rest and reduced sympathetic reactivity to stimuli. Increased resting activity was indicated by a higher LF/HF ratio compared to controls (1.7 ± 1.23 vs 0.9 ± 0.75, p = 0.002); decreased reactivity by a greater BP fall during valsalva (-19 ± 12 vs -8 ± 10, p < 0.001), and a smaller initial diastolic BP increase during tilt (7% vs 14%, p = 0.032). Orthostatic intolerance was significantly more prevalent in EDS-HT than controls (74% vs 34%) and was most frequently expressed as postural orthostatic tachycardia. Lowered QSART responses suggest that sympathetic neurogenic dysfunction is common in patients (p < 0.013), which may explain the dysautonomia in EDS-HT. Further, connective tissue laxity and vasoactive medication use were identified as important factors in aggravating dysautonomia (p < 0.035). CONCLUSION: Dysautonomia consisting of cardiovascular and sudomotor dysfunction is present in EDS-HT. Neuropathy, connective tissue laxity, and vasoactive medication probably play a role in its development.
OBJECTIVES: Many non-musculoskeletal complaints in EDS-HT may be related to dysautonomia. This study therefore aims to investigate whether dysautonomia is present and to explore the underlying mechanisms. METHODS: A total of 39 females with EDS-HT and 35 age-matched controls underwent autonomic function testing. Resting autonomic tone was assessed using heart rate variability (frequency domain) and baroreflex sensitivity analysis (cross correlation). Autonomic reactivity was assessed using the Autonomic Reflex Screen test battery. Factors suspected to contribute to dysautonomia, e.g., neuropathy, medication use, decreased physical activity, depression, pain-induced sympathetic arousal, and connective tissue laxity, were quantified using validated questionnaires, the Beighton score, and measurement of skin extensibility. RESULTS: The EDS-HT group showed autonomic deregulation with increased sympathetic activity at rest and reduced sympathetic reactivity to stimuli. Increased resting activity was indicated by a higher LF/HF ratio compared to controls (1.7 ± 1.23 vs 0.9 ± 0.75, p = 0.002); decreased reactivity by a greater BP fall during valsalva (-19 ± 12 vs -8 ± 10, p < 0.001), and a smaller initial diastolic BP increase during tilt (7% vs 14%, p = 0.032). Orthostatic intolerance was significantly more prevalent in EDS-HT than controls (74% vs 34%) and was most frequently expressed as postural orthostatic tachycardia. Lowered QSART responses suggest that sympathetic neurogenic dysfunction is common in patients (p < 0.013), which may explain the dysautonomia in EDS-HT. Further, connective tissue laxity and vasoactive medication use were identified as important factors in aggravating dysautonomia (p < 0.035). CONCLUSION:Dysautonomia consisting of cardiovascular and sudomotor dysfunction is present in EDS-HT. Neuropathy, connective tissue laxity, and vasoactive medication probably play a role in its development.
Authors: James K Ruffle; Steven J Coen; Vincent Giampietro; Steven C R Williams; A Vania Apkarian; Adam D Farmer; Qasim Aziz Journal: Hum Brain Mapp Date: 2017-10-28 Impact factor: 5.038
Authors: Jessica A Eccles; Beth Thompson; Kristy Themelis; Marisa L Amato; Robyn Stocks; Amy Pound; Anna-Marie Jones; Zdenka Cipinova; Lorraine Shah-Goodwin; Jean Timeyin; Charlotte R Thompson; Thomas Batty; Neil A Harrison; Hugo D Critchley; Kevin A Davies Journal: Clin Med (Lond) Date: 2021-01 Impact factor: 2.659
Authors: Jessica A Eccles; Andrew P Owens; Christopher J Mathias; Satoshi Umeda; Hugo D Critchley Journal: Front Neurosci Date: 2015-02-10 Impact factor: 4.677
Authors: Tania Ruiz Maya; Veronica Fettig; Lakshmi Mehta; Bruce D Gelb; Amy R Kontorovich Journal: Am J Med Genet A Date: 2021-07-30 Impact factor: 2.802